Skip to content
10-Q

Quarterly Report

Guardian Pharmacy Services, Inc. GRDN

0001193125-25-117801

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2025 · Mar 31, 2025 $14M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $4.66M
Current Liabilities Q1 2025 · Mar 31, 2025 $145.3M
Current Liabilities Q1 2025 · Dec 31, 2024 $144.12M
Total Liabilities Q1 2025 · Mar 31, 2025 $170.78M
Total Liabilities Q1 2025 · Dec 31, 2024 $170.83M
Current Assets Q1 2025 · Mar 31, 2025 $166.04M
Current Assets Q1 2025 · Dec 31, 2024 $151.99M
Total Assets Q1 2025 · Mar 31, 2025 $334M
Total Assets Q1 2025 · Dec 31, 2024 $320.81M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $8.65M
Stockholders Equity Q1 2025 · Mar 31, 2024 $56.57M
Stockholders Equity Q1 2025 · Dec 31, 2023 $59.86M
Sga Expense Q1 2025 · Mar 31, 2024 $47.17M
Operating Income Q1 2025 · Mar 31, 2024 $7.93M
Gross Profit Q1 2025 · Mar 31, 2024 $55.1M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $220.31M
Revenue Q1 2025 · Mar 31, 2024 $275.41M